Triodos Groenfonds 주식 가격. TRIGF - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
유럽
EU
Triodos Groenfonds Inc (TRIGF) 시세

Triodos Groenfonds Inc (TRIGF)

56.61

-0.02

( -0.04% )

업데이트: 18:01:01

개인 투자자를 위한 전문가급 도구.

가격

56.61

매수가

0.00

매도가

0.00

거래량

10,394

56.61 일간 변동폭 56.61

53.39 52주 범위 56.72

전일 종가

56.63

개장가

56.61

최근 거래 시간

마지막 거래 시간

18:01:01

평균 볼륨(3m)

13,624

재정 규모

-

VWAP

-

No news to show yet.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.09	-0.15873015873	56.7	56.72	56.54	6789	56.65469202	DE
4	0.4	0.711617149973	56.21	56.72	56.19	8563	56.45043346	DE
12	0.67	1.19771183411	55.94	56.72	55.91	13624	56.26204602	DE
26	1.75	3.18993802406	54.86	56.72	54.86	9957	55.95776361	DE
52	3.13	5.8526551982	53.48	56.72	53.39	8033	55.1717157	DE
156	-1.11	-1.92307692308	57.72	58.19	50.93	8659	53.83565679	DE
260	-3.27	-5.46092184369	59.88	60.77	50.93	10818	56.63893763	DE

TRIGF - Frequently Asked Questions (FAQ)

What is the current Triodos Groenfonds share price?

The current share price of Triodos Groenfonds is 56.61 €

What is the 1 year trading range for Triodos Groenfonds share price?

Triodos Groenfonds has traded in the range of 53.39 € to 56.72 € during the past year

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ALCYBCybergun	0.0002 € (100.00%)	9.8M
CYADCelyad Oncology SA	0.815 € (94.28%)	694.86k
ALNEVNeovacs	0.1281 € (20.96%)	547.64k
PARROParrot	4.66 € (20.10%)	40.04k
MLGALGaleo Concept	2.50 € (19.05%)	148
BELUBeluga NV	0.438 € (-70.80%)	1k
ARFDSAdeunis DS	0.048 € (-52.00%)	5.55k
HDFHydrogene De France	6.45 € (-17.10%)	47.11k
MLIMLImalliance	0.216 € (-16.92%)	4.16k
MLLOILocasystem International	11.50 € (-14.18%)	62
ATOAtos SE	0.0034 € (17.24%)	3.13B
ALVERVergnet	0.0005 € (0.00%)	59.34M
ALEUPEuroplasma	0.0128 € (0.00%)	24.37M
BCPBanco Comercial Portugues SA	0.5396 € (0.11%)	17.62M
LATLatecoere	0.0105 € (8.25%)	14.6M

i_like_bb_stock

i_like_bb_stock 3 분 전

ADIA news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906

i_like_bb_stock

i_like_bb_stock 3 분 전

Juntao

Juntao 3 분 전

i_like_bb_stock

i_like_bb_stock 3 분 전

news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906

i_like_bb_stock

i_like_bb_stock 4 분 전

ADIA news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906

IhidfromtheX

IhidfromtheX 4 분 전

Ok...Talk of the FDA slowing down etc...No problem here... https://finance.yahoo.com/news/chimerix-announces-fda-acceptance-priority-120000372.html

Sideem

Sideem 4 분 전

Good to see the pre-green. Will the green stay?

georgie18

georgie18 4 분 전

AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...

georgie18

georgie18 5 분 전

AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...

Here Today

Here Today 5 분 전

Huge Believer and buyer of shares of more than 9.99% of all Outstanding Shares

https://www.sec.gov/Archives/edgar/data/1829635/000095017025021455/xslSCHEDULE_13G_X01/primar

georgie18

georgie18 5 분 전

AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...

Crawfors

Crawfors 5 분 전

46.5% margins are pretty dang impressive. Can't be upset about that.

$EDXC

georgie18

georgie18 5 분 전

AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...

TheFinalCD

TheFinalCD 5 분 전

https://x.com/NuntioBot/status/1891835713668161922

Crawfors

Crawfors 5 분 전

• Revenue increased 164% year-over-year, reaching $632K in Q4 2024, demonstrating growing demand for our products.

• Our gross margin improved to 46.5%, indicating enhanced financial efficiency.

$EDXC

Crawfors

Crawfors 6 분 전

Acknowledging the Challenges
It’s no secret that our financial position has been strained, with limited working capital and a heavy reliance on convertible financing in the past. We’ve experienced dilution, debt pressure, and cash flow constraints, all of which have made it difficult to opera

Torez

Torez 6 분 전

Lots of comedians in here. Short bus party not a yaht party for you all

Crawfors

Crawfors 6 분 전

https://www.newmediawire.com/news/endexx-corporation-announces-filing-of-q4-2024-financials-removal-of-yield-sign-and-ceo-update-on-growth-strategy-7079432?fbclid=IwY2xjawIhZiJleHRuA2FlbQIxMAABHbyr1bnNTeqMN7dIxtbLtKWPJT_Z-BarsdskOUFhhbk4Yv8wmDhd56UjXg_aem_MXr--hJ2dCo1HspBvETtkA

newmedman

newmedman 7 분 전

Bombs are going to fly. If you thought trump was a dumbfuck just wait for what's coming.

RobotDroid

RobotDroid 7 분 전

A no name reasearch group spews fiction for the paid pumpers. Wow, not impressive at all. Hopium rules, reality falls!

AyaStocks

AyaStocks 7 분 전

GM $ADIA players! Watching for a move back up to higher levels today. This is way undervalued here below a dime.

Crawfors

Crawfors 8 분 전

Here Today

Here Today 8 분 전

Watch Out FDA!!!! There is a new Sheriff in town and all your CROOKED DEALS with those Big Pharma's of the world trying to STOP and Destroy new Treatments and or cures before they can begin is coming to an end in my opinion!!!!

fredscott36

fredscott36 8 분 전

25/marty to venable.

...

georgie18

georgie18 9 분 전

SEPN...$13.70...🥳...T3 Halt...

georgie18

Member Level
Re: georgie18 post# 674144

Friday, February 14, 2025 3:31:11 PM

Post#
674545
of 674615
SEPN...$13.03...🥳...Slowly creeping up...

Triodos Groenfonds

Destination Italia

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관